En-bloc resection of bladder tumour as primary treatment for patients with non-muscle-invasive bladder cancer: routine implementation in a multi-centre setting.


Journal

World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 19 11 2020
accepted: 16 03 2021
pubmed: 29 3 2021
medline: 1 2 2022
entrez: 28 3 2021
Statut: ppublish

Résumé

To investigate the technical success rate and 30-day complications of en-bloc resection of bladder tumour (ERBT) upon routine implementation regardless of tumour size. This is a prospective, multi-centre, study on routine implementation of ERBT for patients with bladder tumours requiring transurethral surgery. Surgeons were allowed to cross over to conventional transurethral resection of bladder tumour (TURBT) when necessary. We performed an analysis for patients who had ERBT/TURBT as the definitive treatment. Study outcomes included the technical success rate of ERBT and 30-day complication rate. Multivariate logistic regression analysis was performed to investigate for predictors of a successful ERBT and factors associated with 30-day complications. A total of 135 patients were included in this study. The majority of the patients (80.0%) had bladder tumours of ≤ 3 cm. ERBT was successful in 99 patients, resulting in an overall technical success rate of 73.3%. When stratified according to tumour size, the technical success rates of ERBT were 94.3%, 82.2%, 75%, 84.3% and 29.6% for bladder tumour sizes of < 1 cm, 1.01-2 cm, 2.01-3 cm, ≤ 3 cm and > 3 cm respectively. Upon multivariate analysis, tumour size was the only significant factor predicting the success of ERBT (OR 0.920, 95% CI 0.882-0.960, p < 0.001). Moreover, ERBT was not a significant factor associated with 30-day complications. EBRT achieved a good technical success rate for the majority of patients with bladder tumours ≤ 3 cm. Regardless of tumour size, EBRT-first approach was safe to implement into routine clinical practice.

Identifiants

pubmed: 33774705
doi: 10.1007/s00345-021-03675-9
pii: 10.1007/s00345-021-03675-9
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

3353-3358

Subventions

Organisme : General Research Fund and Early Career Scheme 2018-2019
ID : 24116518
Organisme : General Research Fund and Early Career Scheme 2020-2021
ID : 14120620

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Jones HC, Swinney J (1962) The treatment of tumours of the bladder by transurethral resection. Br J Urol 34:215–220
doi: 10.1111/j.1464-410X.1962.tb06513.x
Mostafid H, Babjuk M, Bochner B, Lerner SP, Witjes F, Palou J et al (2020) Transurethral resection of bladder tumour: the neglected procedure in the technology race in bladder cancer. Eur Urol 77:669–670
doi: 10.1016/j.eururo.2020.03.005
Brausi M, Collette L, Kurth K, van der Meijden AP, Oosterlinck W, Witjes JA et al (2002) Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol 41:523–531
doi: 10.1016/S0302-2838(02)00068-4
Poletajew S, Krajewski W, Kaczmarek K, Kopczynski B, Stamirowski R, Tukiendorf A et al (2020) The learning curve for transurethral resection of bladder tumour: how many is enough to be independent, safe and effective surgeon? J Surg Educ 77:978–985
doi: 10.1016/j.jsurg.2020.02.010
Kitamura K, Kataoka K, Fujioka H, Kashiwai K (1980) Transurethral resection of a bladder tumor by the use of a polypectomy snare. J Urol 124:808–809
doi: 10.1016/S0022-5347(17)55675-X
Mori K, D’Andrea D, Enikeev DV, Egawa S, Shariat SF (2020) En bloc resection for nonmuscle invasive bladder cancer: review of the recent literature. Curr Opin Urol 30:41–47
doi: 10.1097/MOU.0000000000000697
Parekh DJ, Reis IM, Castle EP, Gonzalgo ML, Woods ME, Svatek RS et al (2018) Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial. Lancet 391:2525–2536
doi: 10.1016/S0140-6736(18)30996-6
Weldon TE, Soloway MS (1975) Susceptibility of urothelium to neoplastic cellular implantation. Urology 5:824–827
doi: 10.1016/0090-4295(75)90367-2
Mostafid H, Kamat AM, Daneshmand S, Palou J, Taylor JA, McKiernan J, Catto J, Babjuk M, Soloway M (2021) Best Practices to Optimise Quality and Outcomes of Transurethral Resection of Bladder Tumours. European Urology Oncology 4(1):12–19
doi: 10.1016/j.euo.2020.06.010
Sylvester RJ, Oosterlinck W, Holmang S, Sydes MR, Birtle A, Gudjonsson S et al (2016) Systematic review and individual patient data meta-analysis of randomized trials comparing a single immediate instillation of chemotherapy after transurethral resection with transurethral resection alone in patients with stage pTa-pT1 urothelial carcinoma of the bladder: which patients benefit from the instillation? Eur Urol 69:231–244
doi: 10.1016/j.eururo.2015.05.050
Teoh JY, MacLennan S, Chan VW, Miki J, Lee HY, Chiong E et al (2020) An international collaborative consensus statement on en bloc resection of bladder tumour incorporating two systematic reviews, a two-round Delphi survey, and a consensus meeting. Eur Urol. https://doi.org/10.1016/j.eururo.2020.04.059
doi: 10.1016/j.eururo.2020.04.059 pubmed: 32972792 pmcid: 7347487
Sureka SK, Agarwal V, Agnihotri S, Kapoor R, Srivastava A, Mandhani A (2014) Is en-bloc transurethral resection of bladder tumor for non-muscle invasive bladder carcinoma better than conventional technique in terms of recurrence and progression?: A prospective study. Indian J Urol 30:144–149
doi: 10.4103/0970-1591.126887
Cheng YY, Sun Y, Li J, Liang L, Zou TJ, Qu WX et al (2018) Transurethral endoscopic submucosal en bloc dissection for nonmuscle invasive bladder cancer: a comparison study of HybridKnife-assisted versus conventional dissection technique. J Cancer Res Ther 14:1606–1612
doi: 10.4103/jcrt.JCRT_786_17
Naselli A, Introini C, Germinale F, Spina B, Puppo P (2012) En bloc transurethral resection of bladder lesions: a trick to retrieve specimens up to 4.5 cm. BJU Int. 109:960–963
doi: 10.1111/j.1464-410X.2012.10982.x
Gregg JR, McCormick B, Wang L, Cohen P, Sun D, Penson DF et al (2016) Short term complications from transurethral resection of bladder tumor. Can J Urol 23:8198–8203
pubmed: 27085823
Nieder AM, Meinbach DS, Kim SS, Soloway MS (2005) Transurethral bladder tumor resection: intraoperative and postoperative complications in a residency setting. J Urol 174:2307–2309
doi: 10.1097/01.ju.0000181797.19395.03
Matulewicz RS, Sharma V, McGuire BB, Oberlin DT, Perry KT, Nadler RB (2015) The effect of surgical duration of transurethral resection of bladder tumors on postoperative complications: an analysis of ACS NSQIP data. Urol Oncol 33(338):e19-24
Teoh JY, Chan ES, Yip SY, Tam HM, Chiu PK, Yee CH et al (2017) Comparison of detrusor muscle sampling rate in monopolar and bipolar transurethral resection of bladder tumor: a randomized trial. Ann Surg Oncol 24:1428–1434
doi: 10.1245/s10434-016-5700-7

Auteurs

Jeremy Yuen-Chun Teoh (JY)

Department of Surgery, S.H. Ho Urology Centre, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China. jeremyteoh@surgery.cuhk.edu.hk.

Nikhil Mayor (N)

Department of Urology, Royal Surrey County Hospital, Guildford, Surrey, UK.

Kai-Man Li (KM)

Department of Surgery, North District Hospital, Hong Kong, China.

Ka-Lun Lo (KL)

Department of Surgery, North District Hospital, Hong Kong, China.

Chi-Fai Ng (CF)

Department of Surgery, S.H. Ho Urology Centre, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.

Hugh Mostafid (H)

Department of Urology, Royal Surrey County Hospital, Guildford, Surrey, UK. mostafid@me.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH